10-Q: Streamex Corp. Q3 Loss Widens Amid Strategic Shift & Acquisition

Streamex Corp. reported a significantly wider net loss in Q3 2025, driven by its strategic acquisition of Streamex Exchange and a pivot towards digital commodity trading and blockchain technology.

Summary

• Streamex Corp. (formerly BioSig Technologies, Inc.) completed the acquisition of Streamex Exchange Corporation on May 28, 2025, and subsequently changed its corporate name and Nasdaq ticker to STEX.
• The company is transitioning its strategic focus from medical device technology (PURE EP Platform) to building digital tools and platforms for commodity trading and finance, with an initial emphasis on gold-backed financial products.
• Net loss for the nine months ended September 30, 2025, increased substantially to $38.751 million, compared to a net loss of $9.240 million for the same period in 2024.
• Revenue for the nine months ended September 30, 2025, was $0, a decrease from $27 thousand in the prior year, as Streamex Exchange is currently in the development stage and pre-revenue.
• General and administrative expenses surged by 159% to $27.365 million for the nine months ended September 30, 2025, primarily due to acquisition-related professional fees, consulting costs, and stock-based compensation.
• Cash used in operating activities increased to $7.416 million for the nine months ended September 30, 2025, from $4.284 million in the prior year.
• The company reported a working capital deficit of $111 million and an accumulated deficit of $294.113 million as of September 30, 2025, raising substantial doubt about its ability to continue as a going concern.
• Shareholders approved several key proposals on September 5, 2025, including increasing authorized common stock to 500 million shares and expanding the 2023 Long-Term Incentive Plan.
• On November 4, 2025, shareholders approved the issuance of common stock exchangeable for Exchangeable Shares, removing the conversion cap and reclassifying the associated derivative liability to permanent equity, which increased stockholders' equity above Nasdaq's minimum requirement.
• The company secured significant financing commitments, including a Senior Secured Convertible Debenture Purchase Agreement for up to $100 million and a Standby Equity Purchase Agreement (SEPA) for up to $1 billion with Yorkville.
• The first closing of the convertible debenture with Yorkville occurred on November 4, 2025, providing $24 million in net proceeds, with $12.6 million allocated to purchase vaulted gold bullion as collateral.
• Material weaknesses in internal control over financial reporting were identified, related to stock-based compensation, period-end financial disclosure, segregation of duties, and accounting for business combinations.
• The company entered into a Tokenized Yield Partnership Agreement with Monetary Metals & Co. on September 8, 2025, to develop blockchain-based financial products tokenizing precious-metal yields.

Sentiment

Score: 3

Explanation: The sentiment is largely negative due to significant financial losses, a substantial working capital deficit, and explicit going concern warnings. While the strategic pivot and capital raises offer future potential, the immediate financial health and operational challenges, including internal control weaknesses, outweigh the positives for the reported period.

Positives

• Successful acquisition of Streamex Exchange Corporation, marking a strategic pivot into the high-growth digital commodity trading and blockchain sector.
• Significant capital raises through a public offering ($13.62 million net) and at-the-market sales ($3.882 million net) during the nine months ended September 30, 2025, improving the cash position to $11.045 million.
• Secured substantial future financing commitments, including up to $100 million in convertible debentures and a $1 billion Standby Equity Purchase Agreement with Yorkville, providing potential long-term capital.
• Shareholder approval on November 4, 2025, removed the conversion cap on Exchangeable Shares, reclassifying a $115.7 million derivative liability to permanent equity and addressing Nasdaq listing requirements.
• Appointment of Henry McPhie, co-founder and former CEO of Streamex Exchange, as the new CEO, signaling a clear leadership direction for the new strategic focus.
• Entry into an exclusive, multi-year Tokenized Yield Partnership Agreement with Monetary Metals & Co. to develop blockchain-based financial products, indicating strategic execution in the new business area.
• Recorded an income tax benefit of $765 thousand for the nine months ended September 30, 2025, due to the reversal of a deferred tax liability in the Canadian subsidiary.

Negatives

• Net loss for the nine months ended September 30, 2025, significantly widened to $38.751 million from $9.240 million in the prior year, primarily due to acquisition-related expenses and a change in fair value of derivative liability.
• Zero revenue reported for the nine months ended September 30, 2025, compared to $27 thousand in the prior year, as the new Streamex Exchange business is pre-revenue and the legacy medical device business generated no sales.
• Working capital deficit of $111 million and an accumulated deficit of $294.113 million as of September 30, 2025, indicate severe liquidity issues and raise substantial doubt about the company's ability to continue as a going concern.
• Cash used in operating activities increased to $7.416 million for the nine months ended September 30, 2025, reflecting an increased cash burn rate.
• General and administrative expenses increased by 159% to $27.365 million, largely due to non-recurring acquisition costs and significant stock-based compensation.
• A large negative swing in other income (expense), net, to $(10.055) million from $2.439 million, primarily driven by a $10.214 million change in the fair value of the derivative liability.
• Material weaknesses were identified in internal control over financial reporting, indicating deficiencies in financial reporting processes and controls.
• The company does not currently have sufficient cash or committed financing to fund operations for the twelve months following the issuance of the 10-Q, despite recent capital raises.

Risks

• Substantial doubt about the company's ability to continue as a going concern due to recurring net losses, negative cash flows from operations, and a significant working capital deficit.
• Dependence on securing additional financing, with no assurance that funding will be available on acceptable terms, potentially leading to delays or elimination of R&D programs and commercialization efforts.
• Risk of dilution to existing shareholders from future equity or debt financings, or the issuance of securities with senior rights.
• The Series C Preferred Stock includes triggering events that may require redemption at a premium, potentially creating a significant liquidity obligation that the company may not be able to satisfy.
• Uncertainty regarding the successful completion and market adoption of Streamex Exchange's technology platforms and future enhancements, as the business is currently pre-revenue.
• Exposure to market volatility and macroeconomic conditions that could adversely affect the ability to raise capital.
• Material weaknesses in internal control over financial reporting could negatively impact the ability to accurately report financial condition and results of operations in a timely manner, leading to regulatory actions or loss of investor confidence.
• The company takes tax positions, including stock-based compensation reporting, that may not be accepted by the IRS, potentially leading to penalties.

Future Outlook

The company expects to continue incurring operating losses and negative cash flows until its products, including the PURE EP Platform and Streamex Exchange's blockchain solutions, achieve sustained commercial success. Streamex Exchange is currently in the development stage and pre-revenue, with initial revenue expected upon the launch of its tokenized gold financing product. Management anticipates increased spending to accelerate the development of the Streamex Exchange platform, which will increase near-term cash requirements. The company is actively exploring various funding sources to address liquidity needs and support commercialization, R&D, and infrastructure expansion.

Management Comments

• Management believes that its assumptions are based upon reasonable data derived from and known about its business and operations.
• Management expects research and development activity to resume at normalized levels in future periods after temporary reallocation of resources to support the Streamex Exchange acquisition.
• Management believes that the company is not exposed to heightened risk from geographic concentration, given the nature of the assets, the stability of the Canadian jurisdiction, and the strategic alignment of the Streamex Exchange business with the company's broader operations.
• Management believes the likelihood of cancellation of the TriView Capital Ltd. agreement is remote.
• Management believes it is probable that shareholder approval for the Exchangeable Shares will be obtained within the specified period, and therefore, the contingency is not considered to represent a currently estimable obligation under ASC 805 (as of Sep 30, 2025).

Industry Context

Streamex Corp.'s strategic pivot from a medical device technology company (electrophysiology solutions) to a digital commodity trading and blockchain platform represents a significant shift. This move aligns with broader industry trends towards the tokenization of real-world assets (RWAs) and the integration of blockchain technology into traditional finance. While the medical device sector offers established markets, the RWA tokenization space is emerging, promising high growth but also carrying higher developmental and regulatory risks. The company's focus on gold-backed financial products positions it within a niche that seeks to bridge traditional asset classes with decentralized finance, potentially attracting a new investor base and market segment.

Comparison to Industry Standards

• The company's current pre-revenue status for its new blockchain business (Streamex Exchange) is typical for early-stage technology ventures in the RWA tokenization space, where significant development and regulatory groundwork are required before commercial launch.
• The substantial increase in general and administrative expenses, driven by acquisition costs and stock-based compensation, is common for companies undergoing significant strategic transformations and M&A activities, though the magnitude of the increase (159%) is notable.
• The identified material weaknesses in internal control over financial reporting, particularly concerning business combinations and stock-based compensation, suggest a need for enhanced financial infrastructure, which is a common challenge for smaller reporting companies undergoing rapid expansion or complex transactions, but below global benchmarks for financial integrity.
• The company's reliance on equity and convertible debt financing (e.g., Yorkville agreements) is a standard approach for growth-stage companies with significant capital requirements and limited operating cash flow, similar to many emerging technology firms.

Management Changes

Corporate Governance

Legal Proceedings

• Settled a litigation threat received on February 22, 2024, for alleged unlawful actions, with a payment of $494,000 made on April 24, 2025.
• May be subject at times to other legal proceedings and claims arising in the ordinary course of business, with occasional adverse decisions or settlements not expected to have a material adverse effect on financial position, results of operations, or liquidity.

Related Party Transactions

• Accounts payable and accrued expenses include approximately $499,000 due to related parties as of September 30, 2025, primarily for executive and board compensation, severance, and reimbursements.
• An amount of $11,000 is due from Henry McPhie, the company's new Chief Executive Officer and Board of Directors, as of September 30, 2025.
• Issued 235,000 shares of common stock to Ferdinand Groenewald, the Interim Chief Financial Officer, with a total grant-date fair value of $0.95 million during the nine months ended September 30, 2025.
• Issued 2,198,345 shares of common stock to Anthony Amato, the former Chief Executive Officer, with an aggregate grant date fair value of $5.9 million, primarily in connection with his resignation and accelerated equity awards due to the Streamex Exchange acquisition.

Stakeholder Impact

• **Shareholders**: Face significant dilution risk from ongoing and planned equity raises, including the conversion of Exchangeable Shares and potential sales under the SEPA. The substantial net loss and going concern warning indicate a negative impact on shareholder value. However, the strategic pivot and new financing could offer long-term growth potential if successful.
• **Employees**: The strategic shift and acquisition led to management changes (new CEO) and a temporary reallocation of R&D resources. The increase in stock-based compensation suggests efforts to incentivize and retain key personnel, particularly in the new blockchain business.
• **Customers**: The legacy PURE EP Platform business generated no revenue, indicating a potential decline in customer base or sales. The new Streamex Exchange business is pre-revenue, so direct customer impact is currently limited, but future success depends on market adoption of its digital commodity trading platforms.
• **Creditors**: The company's significant working capital deficit and going concern warning pose increased risk for creditors. The secured convertible debentures with Yorkville provide collateral (vaulted gold bullion), which mitigates some risk for that specific debt, but overall financial health remains a concern.
• **Suppliers**: The increase in accounts payable and accrued expenses, including to related parties, suggests ongoing operational expenditures, but the company's liquidity issues could pose risks for timely payments to suppliers.

Next Steps

• Launch Streamex Exchange's tokenized gold financing product to commence revenue-generating activities.
• Continue to build out Streamex Exchange's platform architecture, regulatory framework, and strategic partnerships.
• Implement remediation plans in 2026 to address identified material weaknesses in internal control over financial reporting, including adding sufficient staff and oversight supervision controls.
• Seek to satisfy closing conditions for the second $25 million tranche of the Yorkville convertible debenture and potentially additional debentures up to $50 million.
• File a registration statement with the SEC to register for resale the common stock issuable under the Standby Equity Purchase Agreement (SEPA) with Yorkville.
• Continue to evaluate the investment in TriView Capital Ltd. for impairment and adjust for observable price changes.
• Monitor the Chief Operating Decision Maker's review practices and internal reporting structure to update segment disclosures if discrete financial information is regularly reviewed at a disaggregated level.

Key Dates

Recommendation

The filing presents a dire financial situation with a substantial net loss, zero revenue, and a significant working capital deficit, leading to an explicit 'going concern' warning. While the strategic pivot into blockchain and digital assets, coupled with recent capital raises and future financing commitments, offers a glimmer of long-term potential, the immediate risks are overwhelming. The company's inability to fund operations for the next 12 months, coupled with identified material weaknesses in internal controls, indicates severe operational and financial instability. The high dilution risk from ongoing equity issuances and the contingent nature of some financing further exacerbate the precarious position. A seasoned investor would view these factors as highly unfavorable, suggesting a strong sell recommendation to mitigate further capital loss until there is clear evidence of sustained revenue generation, positive cash flow, and resolution of the going concern and internal control issues.

Keywords

Streamex Corp, STEX, 10-Q, Quarterly Report, SEC Filing, Financial Results, Net Loss, Working Capital Deficit, Going Concern, Acquisition, Streamex Exchange, Blockchain, Digital Assets, Commodity Trading, Tokenization, Real-World Assets, Capital Raise, Convertible Debentures, Standby Equity Purchase Agreement, Internal Controls, Corporate Governance, Henry McPhie, Nasdaq